803
Participants
Start Date
September 30, 2006
Primary Completion Date
May 31, 2017
Study Completion Date
December 31, 2018
Capecitabine
Dose:1000 mg/m2, BD, Day 1-Day 14 Interval: 21 days Cycles: 3 cycles
Adjuvant chemotherapy using PF (5-Fluorouracil )
Cisplatin 80 mg/m2 IV + 5-Fluorouracil 1000 mg/m2/day IV infusion for 96 hr every 28 days for 3 cycles
Induction chemotherapy using PF (5-Fluorouracil)
Cisplatin 100 mg/m2 IV + 5-Fluorouracil 1000 mg/m2/day IV infusion for 120 hr every 21 days for 3 cycles
Cancer Center, Sun Yat Sen University, Guangzhou
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong
Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
Department of Clinical Oncology, Queen Mary Hospital, Hong Kong
Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong
The Hong Kong Anti-Cancer Society
OTHER
hong Kong Cancer Fund
UNKNOWN
Hong Kong Nasopharyngeal Cancer Study Group Limited
OTHER